With an extensive presence in North America, Europe, South America, Australia, New Zealand and South Africa and more recently in the MENA and Asia Pacific region, Accord Healthcare has very rapidly become one of the fastest growing generic pharmaceutical companies. With a robust product portfolio in growth oriented therapies, such as Oncology, Cardiology, Neurology, Nephrology, Urology, Psychiatry, Diabetology, Pain management and Gastroenterology and over 5500 product approvals (as of April, 2015) in various markets, Accord’s sales, marketing and distribution network now reaches over 60 countries.
Within a short span of 6 years Accord Healthcare SAC has emerged as one of the fastest growing Indian Pharmaceutical Companies in Peru. Accord Healthcare SAC operates out of Lima, the 5th largest city in the Americas and is the Regional Office for Peru and the rest of Latin America (Central America and Caribbean Islands, Andean Countries, Paraguay & Argentina).
With a product portfolio of 31 products, Accord caters to the physicians’ need for therapy options focused on Gastroenterology, Urology and Oncology segments. Accord products are geared to meeting the patients’ expectation of quality medicines at competitive prices. Accord is proud to be one of the preferred suppliers of Government Institutions in Peru and caters to the unmet needs of the market in varied therapeutic areas. Accord has established its presence in both trade and tender markets of Peru and over the years has served all major Peruvian Government entities. Accord products conform to the increasing standards of regulatory requirements for the region.
As part of our growth in the region, Accord intents to launch various specialty generics that have a niche market in the region.
Contact details
Av. Manuel Olguín No. 215-217 Of. 1403
Torre Empresarial Omega
Santiago de Surco, Lima 33, Peru
+51 1 435 6735
www.accord-healthcare.com